Europe Pepsin Market

Europe Pepsin Market Size (2022 To 2027)

The pepsin market in Europe is estimated to grow from USD 9.78 million in 2022 to USD 11.53 million by 2027, growing at a CAGR of 3.34% from 2022 to 2027.

Drastic changes in lifestyle and increasing consumption of ready-to-eat food are promoting the growth of the pepsin market in the European region. In recent years, owing to the increasing usage of smart gadgets and smartphones, most people are addicted to using the technology and neglecting basic tasks such as household chores and exercise, which resulted in the growing incidence of obesity and gastric problems. In addition, rising stress and busy everyday life leads to neglect of exercise and increasing consumption of junk food at work, which produces gas in the stomach, resulting in digestion problems, boosts the European pepsin market growth.

In addition, the growing usage of pepsin in the food industry is expected to promote the growth rate of the European pepsin market during the forecast period. For instance, Pepsin is used for twisting during cheese production, and it is also used for modifying soybean protein. Furthermore, the growing employment among women in Europe leads to the growing consumption of ready-to-eat foods, as pepsin is used in non-dairy snacks and pre-cooked cereals. Likewise, it is expected to boost the pepsin market growth during the forecast period. Furthermore, in recent years, the younger generation has shown interest in instant foods of various types supporting the growth of the European pepsin market.

Furthermore, the growing prevalence of indigestion disorders in the European region is another major factor promoting the European pepsin market growth. The digestive metabolism of the aging population maybe become weaker due to age, which requires them to take external medication such as Pepsin for good digestion. Indigestion disorder may lead to several chronic diseases, such as gastrointestinal cancer, issues with bowel syndrome, and others, and therefore is essential to receive proper treatment for the problem. Furthermore, the rising demand for pepsin usage in various pharmaceutical drugs further boosts the growth rate of the European pepsin market. Due to the growing demand and supply of pepsin drugs, the key market players have increased their investments in manufacturing them in various forms, such as powder, tablets, liquid form, and others.

However, side effects of the consumption of pepsin, such as gallstones, diarrhea, and a high amount of uric acid in the blood, are one of the major factors hampering the market’s growth rate in Europe. In addition, the high costs associated with pepsin and the availability of low-cost alternative drugs are hindering the pepsin market growth in Europe.

This research report on the European pepsin market has been segmented and sub-segmented into the following categories.

By Type:

• High Activity (min. 1:10000)
• Low Activity (below 1:10000)

By Application:

• Pharmaceuticals
• Inspection & Quarantine
• Health Supplements
• Others

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the European region captured the second largest share of the global market in 2021 and is anticipated to hold a considerable share of the worldwide market during the forecast period owing to the factors such as the increasing availability of pepsin-based drugs and increased awareness about the benefits of Pepsin among people. In addition, several programs have been conducted by the government and healthcare organizations to explain the importance of the digestive system and how it can be improved by using pepsin. These programs also explain that pepsin drugs can be taken without any doctor's prescription.

The UK led the European market in 2021 and is expected to hold considerable of the European market during the forecast period. The United Kingdom is one of the largest exporters of pepsin-based products globally. The presence of many local manufacturers of pepsin in the UK and the availability of pepsin-related products at an affordable cost are promoting the growth rate of the UK market. In addition, the growing availability of pepsin drugs in online pharmacies is boosting the UK market growth.

The German market is anticipated to witness a healthy CAGR during the forecast period.

KEY MARKET PLAYERS:

Feideli Pharmaceuticals, Calzyme laboratories, Inc., Aldon Corporation, Creative Enzymes, Biolaxi Corporation, Sigma-Aldrich, Promega Corporation, Thermo Fisher Scientific, Costantino and C. S.P.A. and Mitushi Pharma are some of the promising companies in the European pepsin market.